It is clinically characterized by the lack of main receptors of breast cancer; estrogen receptor (ER) and progesterone receptor (PR), as well as the amplification of human epidermal growth factor 2 (HER2) [3,6,7]. The gene discussed is ESR1; the disease is breast carcinoma.